Amrutanjan Health Care Limited - Asset Resilience Ratio
Amrutanjan Health Care Limited (AMRUTANJAN) has an Asset Resilience Ratio of 61.39% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Amrutanjan Health Care Limited (AMRUTANJAN) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2025)
This chart shows how Amrutanjan Health Care Limited's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Amrutanjan Health Care Limited to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Amrutanjan Health Care Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Amrutanjan Health Care Limited stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs631.16 Million | 14.6% |
| Short-term Investments | Rs2.02 Billion | 46.79% |
| Total Liquid Assets | Rs2.65 Billion | 61.39% |
Asset Resilience Insights
- Very High Liquidity: Amrutanjan Health Care Limited maintains exceptional liquid asset reserves at 61.39% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Amrutanjan Health Care Limited Industry Peers by Asset Resilience Ratio
Compare Amrutanjan Health Care Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
SIMCERE PHARMAC. GRP LTD
F:S2P |
Drug Manufacturers - Specialty & Generic | 0.44% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
Annual Asset Resilience Ratio for Amrutanjan Health Care Limited (2006–2025)
The table below shows the annual Asset Resilience Ratio data for Amrutanjan Health Care Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 43.93% | Rs1.85 Billion ≈ $20.02 Million |
Rs4.21 Billion ≈ $45.57 Million |
-11.53pp |
| 2024-03-31 | 55.46% | Rs2.03 Billion ≈ $22.00 Million |
Rs3.67 Billion ≈ $39.68 Million |
+18.67pp |
| 2023-03-31 | 36.79% | Rs1.33 Billion ≈ $14.41 Million |
Rs3.62 Billion ≈ $39.16 Million |
+3.18pp |
| 2022-03-31 | 33.61% | Rs1.18 Billion ≈ $12.72 Million |
Rs3.50 Billion ≈ $37.84 Million |
+17.34pp |
| 2021-03-31 | 16.28% | Rs446.38 Million ≈ $4.83 Million |
Rs2.74 Billion ≈ $29.66 Million |
-2.72pp |
| 2020-03-31 | 19.00% | Rs390.11 Million ≈ $4.22 Million |
Rs2.05 Billion ≈ $22.21 Million |
-14.96pp |
| 2019-03-31 | 33.95% | Rs637.04 Million ≈ $6.89 Million |
Rs1.88 Billion ≈ $20.29 Million |
-26.18pp |
| 2018-03-31 | 60.14% | Rs998.17 Million ≈ $10.79 Million |
Rs1.66 Billion ≈ $17.95 Million |
+55.48pp |
| 2017-03-31 | 4.66% | Rs75.82 Million ≈ $819.93K |
Rs1.63 Billion ≈ $17.60 Million |
+4.58pp |
| 2015-03-31 | 0.08% | Rs1.02 Million ≈ $10.98K |
Rs1.24 Billion ≈ $13.40 Million |
-0.01pp |
| 2014-03-31 | 0.09% | Rs1.06 Million ≈ $11.42K |
Rs1.20 Billion ≈ $13.01 Million |
+0.03pp |
| 2013-03-31 | 0.06% | Rs766.55K ≈ $8.29K |
Rs1.24 Billion ≈ $13.43 Million |
-2.44pp |
| 2012-03-31 | 2.50% | Rs35.93 Million ≈ $388.57K |
Rs1.43 Billion ≈ $15.52 Million |
+1.82pp |
| 2006-03-31 | 0.68% | Rs2.52 Million ≈ $27.27K |
Rs370.01 Million ≈ $4.00 Million |
-- |
About Amrutanjan Health Care Limited
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn co… Read more